Related Experiment Video
Updated: Feb 21, 2026

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
Published on: November 28, 2019
Shaping death: how the microbiome regulates tumour cell demise and therapy response
Martina Raudenska1,2, Jan Balvan1,2, Eliska Zgarbova1,2,3
1Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Kamenice 5, 625 00, Brno, Czech Republic.
Abstract:
Cell death is a fundamental process that maintains tissue homeostasis and shapes the tumour microenvironment. Cancer cells often evade or reprogram cell death pathways, which leads to malignancy and therapy resistance. On the other hand, the cell death of non-malignant cells significantly influences the adverse effects of anticancer therapy, such as the onset of mucositis or enteritis. Emerging evidence identifies both the tumour and gut microbiomes as critical modulators of these processes. In turn, cell death reshapes the microbial ecosystem by altering nutrient landscapes and immune signalling. Although both cell death and the microbiome are well-studied in cancer, their intersection remains underexplored. This review article addresses this gap by summarising how microbes and microbial metabolites modulate cancer cell death pathways and shape responses to anticancer therapy. We integrated current knowledge on this complex interplay, focusing on key metabolic mediators that can influence cell fate decisions. Understanding this bidirectional crosstalk offers new opportunities to "preserve the good and eliminate the bad" within the tumour-microbiome axis, paving the way for precision microbiome-informed cancer therapies.
Insights
Cancer cell death pathways are modulated by the gut microbiome, impacting cancer malignancy and therapy resistance. Understanding this interplay offers new strategies for microbiome-informed cancer treatments.
Area of Science:
- Oncology
- Microbiology
- Cell Biology
Background:
- Cell death is crucial for tissue homeostasis and the tumor microenvironment.
- Cancer cells often evade cell death, contributing to malignancy and treatment resistance.
- Non-malignant cell death can cause adverse effects during cancer therapy.
Purpose of the Study:
- To review the intersection of cell death and the microbiome in cancer.
- To summarize how microbes and metabolites influence cancer cell death pathways.
- To explore how this crosstalk impacts anticancer therapy response.
Main Methods:
- Literature review integrating knowledge on cell death and microbiome interactions.
- Focus on key metabolic mediators influencing cell fate decisions.
- Analysis of the bidirectional relationship between cell death and microbial ecosystems.
Main Results:
- The tumor and gut microbiomes critically modulate cancer cell death processes.
- Cell death influences microbial ecosystems by altering nutrient availability and immune signaling.
- Microbial metabolites play a role in cancer cell fate decisions.
Conclusions:
- The interplay between cell death and the microbiome is underexplored but critical in cancer.
- Understanding this bidirectional crosstalk opens avenues for precision microbiome-informed cancer therapies.
- Targeting the tumor-microbiome axis can help "preserve the good and eliminate the bad" in cancer treatment.
Related Concept Videos
The Tumor Microenvironment
Tumor Immunotherapy
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Mitogens and the Cell Cycle

